These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma. Vihinen P; Koskivuo I; Syrjänen K; Tervahartiala T; Sorsa T; Pyrhönen S Melanoma Res; 2008 Aug; 18(4):268-73. PubMed ID: 18626311 [TBL] [Abstract][Full Text] [Related]
7. Heterogenous S-100B protein expression patterns in malignant melanoma and association with serum protein levels. Bánfalvi T; Udvarhelyi N; Orosz Z; Gergye M; Gilde K; Tímár J Oncology; 2003; 64(4):374-9. PubMed ID: 12759535 [TBL] [Abstract][Full Text] [Related]
8. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Church SL; Grant JW; Ridnour LA; Oberley LW; Swanson PE; Meltzer PS; Trent JM Proc Natl Acad Sci U S A; 1993 Apr; 90(7):3113-7. PubMed ID: 8464931 [TBL] [Abstract][Full Text] [Related]
9. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma. Nozoe T; Honda M; Inutsuka S; Yasuda M; Korenaga D Oncol Rep; 2003; 10(1):39-43. PubMed ID: 12469142 [TBL] [Abstract][Full Text] [Related]
10. Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma. Baba Y; Funakoshi T; Mori M; Emoto K; Masugi Y; Ekmekcioglu S; Amagai M; Tanese K J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2038-2045. PubMed ID: 28681540 [TBL] [Abstract][Full Text] [Related]
11. Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma. Jury CS; McAllister EJ; MacKie RM Br J Dermatol; 2000 Aug; 143(2):269-74. PubMed ID: 10951132 [TBL] [Abstract][Full Text] [Related]
12. Evaluation and prognostic significance of manganese superoxide dismutase in clear cell renal cell carcinoma. Zhao Z; Lu J; Qu H; Wang Z; Liu Q; Yang X; Liu S; Ge J; Xu Y; Li N; Yuan Y Hum Pathol; 2018 Oct; 80():87-93. PubMed ID: 29935195 [TBL] [Abstract][Full Text] [Related]
13. Serum manganese superoxide dismutase (MnSOD) and histological virulence of ovarian cancer. Nishida T; Sugiyama T; Kataoka A; Tashiro M; Yakushiji M; Ishikawa M Asia Oceania J Obstet Gynaecol; 1993 Dec; 19(4):427-31. PubMed ID: 8135676 [TBL] [Abstract][Full Text] [Related]
14. Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Schadendorf D; Diehl S; Zuberbier T; Schadendorf C; Henz BM Dermatology; 1996; 192(2):89-93. PubMed ID: 8829517 [TBL] [Abstract][Full Text] [Related]
15. Serum matrix metalloproteinase-2 in patients with malignant melanoma. Wollina U; Hipler UC; Knöll B; Graefe T; Kaatz M; Kirsch K J Cancer Res Clin Oncol; 2001 Oct; 127(10):631-5. PubMed ID: 11599800 [TBL] [Abstract][Full Text] [Related]
16. Serum protein s100beta in patients with malignant melanoma detected by an immunoluminometric assay. Wollina U; Karte K; Hipler UC; Knöll B; Kirsch K; Herold C J Cancer Res Clin Oncol; 2000 Feb; 126(2):107-10. PubMed ID: 10664251 [TBL] [Abstract][Full Text] [Related]
17. [Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma]. Guo HB; Stoffel-Wagner B; Brennemann W; Springer W; Klingmüller D J Tongji Med Univ; 1995; 15(1):19-25. PubMed ID: 7783258 [No Abstract] [Full Text] [Related]
18. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Zhong W; Oberley LW; Oberley TD; St Clair DK Oncogene; 1997 Jan; 14(4):481-90. PubMed ID: 9053845 [TBL] [Abstract][Full Text] [Related]
19. S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma. Deichmann M; Benner A; Bock M; Jäckel A; Uhl K; Waldmann V; Näher H J Clin Oncol; 1999 Jun; 17(6):1891-6. PubMed ID: 10561230 [TBL] [Abstract][Full Text] [Related]
20. Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse. Egberts F; Hitschler WN; Weichenthal M; Hauschild A Melanoma Res; 2009 Feb; 19(1):31-5. PubMed ID: 19104452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]